Ambarella Inc. Ordinary Shares (AMBA)
Fast GrowerFairStock Score: 45/100 — MIXED
Key Financials
| Current Price | $81.16 |
| Market Cap | $2.6B |
| P/E Ratio | -50.41 |
| ROE | -11.82% |
| Dividend Yield | —% |
| Sector | Technology |
Strengths
- Generates $87 million in annual free cash flow (3.3% yield on market cap)
- Conservative balance sheet with debt-to-equity of just 0.02, providing financial flexibility
- Altman Z-Score of 7.6 confirms minimal bankruptcy risk and strong solvency
- Revenue growth of 20.1% demonstrates strong top-line momentum
Concerns
- Currently unprofitable—sustained losses could lead to dilutive capital raises or balance sheet deterioration
- Weak Piotroski F-Score of 3/9 suggests deteriorating financial quality across multiple dimensions
AI Analysis
Ambarella Inc. Ordinary Shares is a small-cap technology company valued at $2.6 billion. Revenue stands at $391 million, though the company is currently unprofitable. From a quality standpoint, Ambarella shows weak Piotroski F-Score of 3/9 signaling deteriorating fundamentals and Altman Z-Score of 7.6 confirms fortress-level solvency. On valuation, the stock is 0.6% FCF yield. Growth dynamics show revenue growing at 20.1% and profit growth of 18.8%. Our composite FairStock Score of 45/100 reflects mixed fundamentals overall. Without profitability, this remains speculative—suitable only for those with high risk tolerance and a long time horizon.
Bull Case
Ambarella's 20% revenue growth trajectory could accelerate as it captures additional market share in the technology sector. With $87 million in annual free cash flow (3.3% yield), management has ample capital for buybacks, dividends, or accretive acquisitions.
Bear Case
Without a clear path to profitability, continued cash burn forces either dilutive equity raises or debt accumulation that destroys shareholder value. Regulatory changes, input cost inflation, or demand normalization represent underappreciated risks that could materially impact forward estimates.
Data from SEC filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer